Back to all research

MOTS-c: What the Research Says

July 7, 2026

MOTS-c is a relatively recent discovery that has drawn interest in metabolic and aging research. This overview summarizes what the published research reports, strictly within a laboratory-research context.

What Is MOTS-c?

MOTS-c (“Mitochondrial ORF of the 12S rRNA type-c”) is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region. It was first described in 2015. Research reports that its expression is influenced by stress and exercise and tends to decline with age.

Mechanisms Studied in Research

  • Metabolic regulation. MOTS-c has been studied in relation to glucose uptake, lipid metabolism, and insulin sensitivity in cell and animal models.
  • Exercise-associated signaling. Research describes MOTS-c as responsive to exercise and stress, and has examined it as a mediator of skeletal-muscle adaptation.

Areas of Preclinical Investigation

In diet-induced obese mice, MOTS-c administration was associated with improved insulin sensitivity and increased fat oxidation; animal studies have also examined effects framed as “exercise-mimetic,” such as improved exercise capacity. Human observational work has measured circulating MOTS-c in relation to exercise. These are research findings, not endorsements of human use.

The State of the Evidence

  • Early and largely preclinical. As a compound discovered in 2015, MOTS-c has a growing but still early evidence base concentrated in animal and mechanistic studies.
  • Regulatory status. MOTS-c is not an FDA-approved drug. Research-grade material is supplied for laboratory research use only.

Key Takeaways

  • MOTS-c is a 16-amino-acid mitochondrial-derived peptide discovered in 2015.
  • Research focuses on metabolism, insulin sensitivity, and exercise-associated signaling.
  • The evidence is early and preclinical; it is not FDA-approved.

References

  • Lee C. et al. “MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism.” PMID 27216708.
  • “The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivity.” PMC6640593.
  • “Effect of aerobic and resistance exercise on the mitochondrial peptide MOTS-c...” Scientific Reports, 2021.

Research Use, Legal Status & Handling

Material supplied for research is intended for in-vitro laboratory research use only. It is not a dietary supplement, drug, cosmetic, or food. Where an approved pharmaceutical version of a compound exists, research-grade material is not that approved product and is not intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Researchers are solely responsible for compliance with all applicable federal, state, and local laws and regulations in their jurisdiction. Research peptides are generally stored lyophilized, protected from light and heat, with reconstitution and handling performed per standard laboratory protocols.

Disclaimer: This article is provided for educational and informational purposes only and summarizes published laboratory and, where noted, clinical research. It is not medical advice or a recommendation for any form of use. Research-grade material is intended strictly for in-vitro research use only — not for human or veterinary consumption. Always consult a qualified professional regarding health-related questions.